Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)
Clinical trial NCT03659435 · COMPLETED
Trial details
- NCT number
- NCT03659435
- Sponsor
- SocraTec R&D GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-22
- Primary completion
- 2018-11-28
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.